ET
LH icon

Equitable Trust’s Labcorp LH Stock Holding History

Equitable Trust’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6M Buy
77,107
+1,449
+2% +$392K 0.95% 22
2025
Q4 		$19M Sell
75,658
-770
-1% -$205K 0.85% 25
2025
Q3 		$21.9M Sell
76,428
-999
-1% -$268K 1.01% 24
2025
Q2 		$20.3M Buy
77,427
+2,644
+4% +$644K 1.01% 25
2025
Q1 		$17.4M Sell
74,783
-5,382
-7% -$1.31M 0.96% 24
2024
Q4 		$18.4M Sell
80,165
-7,622
-9% -$1.75M 1.03% 22
2024
Q3 		$19.6M Buy
87,787
+3,468
+4% +$762K 1.26% 16
2024
Q2 		$17.2M Sell
84,319
-42,880
-34% -$8.72M 1.18% 17
2024
Q1 		$27.8M Sell
127,199
-4,043
-3% -$891K 1.93% 8
2023
Q4 		$29.8M Buy
131,242
+17,298
+15% +$3.63M 2.24% 9
2023
Q3 		$22.9M Buy
113,944
+14,231
+14% +$3M 1.89% 11
2023
Q2 		$20.7M Buy
99,713
+10,610
+12% +$2.06M 1.58% 17
2023
Q1 		$17.6M Buy
89,103
+23,666
+36% +$4.87M 1.38% 17
2022
Q4 		$13.2M Buy
+65,437
New +$12.8M 1.04% 24

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Equitable Trust's LH Position: Q1 2026 in Review

Equitable Trust increased its Labcorp (LH) stake by 1.9% in Q1 2026, buying an estimated $392K and bringing the position to 77,107 shares worth $20.6M. The position accounts for 0.95% of the portfolio, ranked #22.

Equitable Trust first reported a position in LH in Q4 2022 and has held it in 14 quarters since. The position peaked at $29.8M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Equitable Trust held 77,107 shares of Labcorp worth $20.6M as of Q1 2026.
  • Equitable Trust bought 1,449 Labcorp shares in Q1 2026, an estimated $392K.
  • Labcorp made up 0.95% of Equitable Trust's portfolio in Q1 2026, its #22 holding.
  • Equitable Trust first reported a position in Labcorp in Q4 2022 and has held it in 14 quarters since.
  • Equitable Trust's Labcorp position peaked at $29.8M in Q4 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.